使用高效快速脑电图进行癫痫发作评估与预测:一项回顾性多中心比较效果研究
这项多中心回顾性研究评估了1小时快速反应脑电图(rrEEG)计算的2HELPS2B评分在预测癫痫风险方面是否不劣于常规脑电图(cEEG)。共纳入240例同时具有rrEEG和后续cEEG的患者,结果显示rrEEG的AUC为0.85(95% CI 0.78-0.90,p=0.001),达到非劣效性;与匹配的cEEG相比AUC无显著差异(0.89,95% CI 0.83-0.94,p=0.31)。结论认为rrEEG在预测癫痫风险方面不劣于cEEG。
要点
- 1小时rrEEG计算的2HELPS2B评分对癫痫风险预测不劣于cEEG(AUC 0.85,95% CI 0.78-0.90,p=0.001)。
- 与匹配的cEEG相比,rrEEG的AUC无显著差异(0.89,95% CI 0.83-0.94,p=0.31)。
- 2HELPS2B=0组的假阴性率rrEEG为0.021(95% CI 0-0.062),cEEG为0.016(95% CI 0-0.048),无显著差异(p=1.0)。
核心结论
- 1小时rrEEG计算的2HELPS2B评分在癫痫预测方面不劣于cEEG。
- 低风险患者(2HELPS2B=0)可能可以放弃延长cEEG监测,从而增加对高危患者的监测。
研究设计与样本
- 多中心回顾性脑电图诊断准确性研究,自2021年10月1日至2022年7月31日,在4个三级医疗中心进行连续采样。
- 纳入2018年1月1日至2022年6月20日期间≥18岁患者的病历和脑电图记录。
- 蒙特卡洛模拟功效分析得出rrEEG样本量n=500;次要结局计划n=500 cEEG并进行倾向评分协变量匹配。
- 实际获得240例同时具有rrEEG和后续cEEG的记录;中位年龄64岁(四分位距22),42%为女性。
主要发现
- 1小时rrEEG的2HELPS2B评分对癫痫风险预测达到非劣效于cEEG(AUC 0.85,95% CI 0.78-0.90,p=0.001)。
- 与匹配的同期cEEG相比,AUC无显著差异(0.89,95% CI 0.83-0.94,p=0.31)。
- 2HELPS2B=0组的假阴性率无显著差异(p=1.0):rrEEG为0.021(95% CI 0-0.062),cEEG为0.016(95% CI 0-0.048)。
- 生存分析无显著差异。
关键数值与推荐
- 非劣效性界值0.05基于2HELPS2B验证研究。
- 主要结局为非劣效性,通过受试者工作特征曲线下面积(AUC)评估。
- 本研究提供II级证据表明rrEEG在计算2HELPS2B评分预测癫痫风险方面不劣于cEEG。
临床怎么用
- 低风险患者(2HELPS2B=0)可能可以放弃延长cEEG监测,从而增加对高危患者的监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Approximately 30% of critically ill patients have seizures, and more than half of these seizures do not have an overt clinical correlate. EEG is needed to avoid missing seizures and prevent overtreatment with antiseizure medications. Conventional-EEG (cEEG) resources are logistically constrained and unable to meet their growing demand for seizure detection even in highly developed centers. Brief EEG screening with the validated 2HELPS2B algorithm was proposed as a method to triage cEEG resources, but it is hampered by cEEG requirements, primarily EEG technologists. Seizure risk-stratification using reduced time-to-application rapid response-EEG (rrEEG) systems (∼5 minutes) could be a solution. We assessed the noninferiority of the 2HELPS2B score on a 1-hour rrEEG compared to cEEG. METHODS: A multicenter retrospective EEG diagnostic accuracy study was conducted from October 1, 2021, to July 31, 2022. Chart and EEG review performed with consecutive sampling at 4 tertiary care centers, included records of patients ≥18 years old, from January 1, 2018, to June 20, 2022. Monte Carlo simulation power analysis yielded n = 500 rrEEG; for secondary outcomes n = 500 cEEG and propensity-score covariate matching was planned. Primary outcome, noninferiority of rrEEG for seizure risk prediction, was assessed per area under the receiver operator characteristic curve (AUC). Noninferiority margin (0.05) was based on the 2HELPS2B validation study. RESULTS: A total of 240 rrEEG with follow-on cEEG were obtained. Median age was 64 (interquartile range 22); 42% were female. 2HELPS2B on a 1-hour rrEEG met noninferiority to cEEG (AUC 0.85, 95% CI 0.78-0.90, p = 0.001). Secondary endpoints of comparison with a matched contemporaneous cEEG showed no significant difference in AUC (0.89, 95% CI 0.83-0.94, p = 0.31); in false negative rate for the 2HELPS2B = 0 group (p = 1.0) rrEEG (0.021, 95% CI 0-0.062), cEEG (0.016, 95% CI 0-0.048); nor in survival analyses. DISCUSSION: 2HELPS2B on 1-hour rrEEG is noninferior to cEEG for seizure prediction. Patients with low-risk (2HELPS2B = 0) may be able to forgo prolonged cEEG, allowing for increased monitoring of at-risk patients. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that rrEEG is noninferior to cEEG in calculating the 2HELPS2B score to predict seizure risk.
引用
- Kalkach-Aparicio M, Fatima S, Selte A, et al. Seizure Assessment and Forecasting With Efficient Rapid-EEG: A Retrospective Multicenter Comparative Effectiveness Study. Neurology. 2024. PMID: 38875512. doi:10.1212/WNL.0000000000209621
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。